215 related articles for article (PubMed ID: 33425026)
1. Building the case for the calcitonin receptor as a viable target for the treatment of glioblastoma.
Gupta P; Furness SGB; Bittencourt L; Hare DL; Wookey PJ
Ther Adv Med Oncol; 2020; 12():1758835920978110. PubMed ID: 33425026
[TBL] [Abstract][Full Text] [Related]
2. Strategic Development of an Immunotoxin for the Treatment of Glioblastoma and Other Tumours Expressing the Calcitonin Receptor.
Gupta P; Hare DL; Wookey PJ
Cells; 2021 Sep; 10(9):. PubMed ID: 34571996
[TBL] [Abstract][Full Text] [Related]
3. Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas.
Ostrovskaya A; Hick C; Hutchinson DS; Stringer BW; Wookey PJ; Wootten D; Sexton PM; Furness SGB
BMC Cancer; 2019 Feb; 19(1):157. PubMed ID: 30777055
[TBL] [Abstract][Full Text] [Related]
4. Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma.
Gilabert-Oriol R; Furness SGB; Stringer BW; Weng A; Fuchs H; Day BW; Kourakis A; Boyd AW; Hare DL; Thakur M; Johns TG; Wookey PJ
Cancer Immunol Immunother; 2017 Sep; 66(9):1217-1228. PubMed ID: 28501939
[TBL] [Abstract][Full Text] [Related]
5. Loss-of-Function Mutations in Calcitonin Receptor (
Pal J; Patil V; Kumar A; Kaur K; Sarkar C; Somasundaram K
Clin Cancer Res; 2018 Mar; 24(6):1448-1458. PubMed ID: 29263181
[No Abstract] [Full Text] [Related]
6. The expression of calcitonin receptor detected in malignant cells of the brain tumour glioblastoma multiforme and functional properties in the cell line A172.
Wookey PJ; McLean CA; Hwang P; Furness SG; Nguyen S; Kourakis A; Hare DL; Rosenfeld JV
Histopathology; 2012 May; 60(6):895-910. PubMed ID: 22335784
[TBL] [Abstract][Full Text] [Related]
7. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
8. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
[TBL] [Abstract][Full Text] [Related]
9. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
[TBL] [Abstract][Full Text] [Related]
10. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of two novel isoforms of the human calcitonin receptor.
Beaudreuil J; Balasubramanian S; Chenais J; Taboulet J; Frenkian M; Orcel P; Jullienne A; Horne WC; de Vernejoul MC; Cressent M
Gene; 2004 Dec; 343(1):143-51. PubMed ID: 15563840
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin induces stem cell-like phenotype in prostate cancer cells.
Aldahish A; Kale A; Aljameeli A; Shah GV
Endocr Relat Cancer; 2019 Nov; 26(11):815-828. PubMed ID: 31561211
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
[TBL] [Abstract][Full Text] [Related]
15. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
16. EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma.
Offenhäuser C; Al-Ejeh F; Puttick S; Ensbey KS; Bruce ZC; Jamieson PR; Smith FM; Stringer BW; Carrington B; Fuchs AV; Bell CA; Jeffree R; Rose S; Thurecht KJ; Boyd AW; Day BW
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30562956
[TBL] [Abstract][Full Text] [Related]
17. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
[TBL] [Abstract][Full Text] [Related]
18. Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth.
Shi Y; Ping YF; Zhou W; He ZC; Chen C; Bian BS; Zhang L; Chen L; Lan X; Zhang XC; Zhou K; Liu Q; Long H; Fu TW; Zhang XN; Cao MF; Huang Z; Fang X; Wang X; Feng H; Yao XH; Yu SC; Cui YH; Zhang X; Rich JN; Bao S; Bian XW
Nat Commun; 2017 Jun; 8():15080. PubMed ID: 28569747
[TBL] [Abstract][Full Text] [Related]
19. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
Chandran UR; Luthra S; Santana-Santos L; Mao P; Kim SH; Minata M; Li J; Benos PV; DeWang M; Hu B; Cheng SY; Nakano I; Sobol RW
Genom Data; 2015 Sep; 5():333-336. PubMed ID: 26251826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
